Biogen’s Salanersen Receives FDA Breakthrough Ther...
Category : ODD/BTA/FTA Status 8 June 2026A Major Step Forward for SMA Treatment Biogen has announced that the U.S. Food and Drug Administr...
Odd Bta Fta Status
Thryv Therapeutics Advances THRV-1268 in Long QT S...
Category : ODD/BTA/FTA Status 27 April 2026Fast Track status + Phase 2/3 dosing marks a critical inflection point. A small biotech just made a...
Eris Lifesciences Disrupts the GLP-1 Market with ₹...
Category : ODD/BTA/FTA Status 23 March 2026The semaglutide price war in India just hit a new low. Eris Lifesciences Limited has launched its ge...
US FDA grants Breakthrough Therapy designation to...
Category : ODD/BTA/FTA Status 20 March 2026Sanofi announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy des...
FDA Grants Breakthrough Therapy Designation to Sut...
Category : ODD/BTA/FTA Status 8 March 2026Hemab Therapeutics has received a major regulatory boost after the U.S. Food and Drug Administration...
Latest Newsletter Post
-
Bayer Completes Acquisition of Perf..
19 June 2026
-
Ananda Pharma Completes Phase 1 Stu..
19 June 2026
-
Gesynta Pharma Reaches Key Recruitm..
18 June 2026
-
Dimerix Partners with Everest Medic..
18 June 2026
-
Istesso Begins Phase 2 Trial of Ler..
17 June 2026
